Dosing guidelines for fluconazole in patients with renal failure

被引：30
作者：
Cousin, L [1 ]
Le Berre, M [1 ]
Launay-Vacher, V [1 ]
Izzedine, H [1 ]
Deray, G [1 ]
机构：
[1] Hop La Pitie Salpetriere, Dept Nephrol, F-75013 Paris, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2003年 / 18卷 / 11期
关键词：
CAPD; CVVH; fluconazole; haemodialysis; renal insufficiency;
D O I：
10.1093/ndt/gfg363
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2227 / 2231
页数：5
相关论文
共 27 条
  • [1] ANDREU CMF, 1999, REV CUBANA MED TROP, V51, P55
  • [2] BERL T, 1995, J AM SOC NEPHROL, V6, P242
  • [3] INCREASED GASTRIC PH AND THE BIOAVAILABILITY OF FLUCONAZOLE AND KETOCONAZOLE
    BLUM, RA
    DANDREA, DT
    FLORENTINO, BM
    WILTON, JH
    HILLIGOSS, DM
    GARDNER, MJ
    HENRY, EB
    GOLDSTEIN, H
    SCHENTAG, JJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (09) : 755 - 757
  • [4] BRAMMER KW, 1991, DRUG METAB DISPOS, V19, P764
  • [5] BREN A, 1992, TRANSPL P, V24, P2765
  • [6] Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis
    Dahl, NV
    Foote, EF
    Searson, KM
    Fein, JL
    Kapoian, T
    Steward, CA
    Sherman, RA
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (12) : 1284 - 1289
  • [7] CLINICAL PHARMACOKINETICS OF FLUCONAZOLE
    DEBRUYNE, D
    RYCKELYNCK, JP
    [J]. CLINICAL PHARMACOKINETICS, 1993, 24 (01) : 10 - 27
  • [8] DUDLEY MN, 1990, PHARMACOTHERAPY, V10, pS141
  • [9] FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES
    GRANT, SM
    CLISSOLD, SP
    [J]. DRUGS, 1990, 39 (06) : 877 - 916
  • [10] PHARMACOKINETIC EVALUATION OF UK-49,858, A METABOLICALLY STABLE TRIAZOLE ANTIFUNGAL DRUG, IN ANIMALS AND HUMANS
    HUMPHREY, MJ
    JEVONS, S
    TARBIT, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 648 - 653
123